Your browser doesn't support javascript.
loading
Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment.
Mallick, Rahul; Bhowmik, Prasenjit; Duttaroy, Asim K.
Afiliação
  • Mallick R; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Finland.
  • Bhowmik P; Department of Chemistry, Uppsala Biomedical Centre, Uppsala University, Sweden.
  • Duttaroy AK; Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway. Electronic address: a.k.duttaroy@medisin.uio.no.
Biomed Pharmacother ; 167: 115591, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37774669
ABSTRACT
Despite scientific development, cancer is still a fatal disease. The development of cancer is thought to be significantly influenced by fatty acids. Several mechanisms that control fatty acid absorption and metabolism are reported to be altered in cancer cells to support their survival. Cancer cells can use de novo synthesis or uptake of extracellular fatty acid if one method is restricted. This factor makes it more difficult to target one pathway while failing to treat the disease properly. Side effects may also arise if several inhibitors simultaneously target many targets. If a viable inhibitor could work on several routes, the number of negative effects might be reduced. Comparative investigations against cell viability have found several potent natural and manmade substances. In this review, we discuss the complex roles that fatty acids play in the development of tumors and the progression of cancer, newly discovered and potentially effective natural and synthetic compounds that block the uptake and metabolism of fatty acids, the adverse side effects that can occur when multiple inhibitors are used to treat cancer, and emerging therapeutic approaches.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia